- Home
- RUMBW vs WGSWW Comparison
RUMBW vs WGSWW Comparison
Compare RUMBW & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUMBW
- WGSWW
- Stock Information
- Founded
- RUMBW 2013
- WGSWW 2017
- Country
- RUMBW United States
- WGSWW United States
- Employees
- RUMBW 135
- WGSWW 1000
- Industry
- RUMBW Computer Software: Prepackaged Software
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- RUMBW Technology
- WGSWW Technology
- Exchange
- RUMBW Nasdaq
- WGSWW Nasdaq
- Market Cap
- RUMBW N/A
- WGSWW N/A
- IPO Year
- RUMBW N/A
- WGSWW N/A
- Fundamental
- Price
- RUMBW $2.15
- WGSWW $0.10
- Analyst Decision
- RUMBW
- WGSWW
- Analyst Count
- RUMBW 0
- WGSWW 0
- Target Price
- RUMBW N/A
- WGSWW N/A
- AVG Volume (30 Days)
- RUMBW 39.1K
- WGSWW 36.6K
- Earning Date
- RUMBW 03-28-2025
- WGSWW 02-18-2025
- Dividend Yield
- RUMBW N/A
- WGSWW N/A
- EPS Growth
- RUMBW N/A
- WGSWW N/A
- EPS
- RUMBW N/A
- WGSWW N/A
- Revenue
- RUMBW $85,651,775.00
- WGSWW $305,450,000.00
- Revenue This Year
- RUMBW N/A
- WGSWW N/A
- Revenue Next Year
- RUMBW N/A
- WGSWW N/A
- P/E Ratio
- RUMBW N/A
- WGSWW N/A
- Revenue Growth
- RUMBW 6.36
- WGSWW 50.79
- 52 Week Low
- RUMBW $4.32
- WGSWW $0.17
- 52 Week High
- RUMBW $4.68
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- RUMBW N/A
- WGSWW N/A
- Support Level
- RUMBW N/A
- WGSWW N/A
- Resistance Level
- RUMBW N/A
- WGSWW N/A
- Average True Range (ATR)
- RUMBW 0.00
- WGSWW 0.00
- MACD
- RUMBW 0.00
- WGSWW 0.00
- Stochastic Oscillator
- RUMBW 0.00
- WGSWW 0.00
About RUMBW Rumble Inc. Warrant
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.